生理性月经期人子宫内膜缺氧标志物的在体与离体检测
前瞻性病例研究纳入16名月经血量正常(<80 ml/周期)的女性,在月经期(第1-3天)及分泌早/中期行动态增强MRI和T2*定量,并采集内膜测定ADM、VEGFA、CXCR4 mRNA。月经期T2*降低(P=0.005)、血浆流量增加(P=0.0005),上述缺氧标志物mRNA升高(P=0.008、0.03、0.009),且T2*与离体标志物相关(P<0.05),支持生理性月经期子宫内膜存在缺氧。
要点
- 月经期子宫内膜T2*降低,提示在体缺氧。
- 月经期血浆流量增加,与缺氧并存。
- 月经期ADM、VEGF-A、CXCR4 mRNA升高。
核心结论
- 在体数据支持生理性月经期妇女子宫内膜存在缺氧。
研究设计与样本
- 前瞻性病例研究,纳入16名月经规律、经量正常(<80 ml/周期)的育龄女性。
主要发现
- 月经期MRI T2*较非月经期降低(P=0.005)。
- 月经期血浆流量(Fp)较非月经期增加(P=0.0005)。
- 配对内膜活检显示月经期ADM、VEGF-A、CXCR4 mRNA升高(P=0.008;P=0.03;P=0.009)。
- T2*与上述离体缺氧标志物显著相关(P<0.05)。
临床怎么用
- 在经量正常且无显著子宫结构异常的女性中,MRI T2*与内膜缺氧标志物或可作为研究性检测。
- 对月经过多(HMB)患者,这些无创检测的诊断与个体化治疗价值尚待研究。
局限性
- 仅纳入经量<80 ml/周期且无显著子宫结构异常的女性。
- 仅在月经周期特定时间点检测。
- 异常子宫出血伴或不伴肌瘤/子宫腺肌病者需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Can markers of human endometrial hypoxia be detected at menstruation in vivo? SUMMARY ANSWER: Our in vivo data support the presence of hypoxia in menstrual endometrium of women during physiological menstruation. WHAT IS KNOWN ALREADY: Current evidence from animal models and human in vitro studies suggests endometrial hypoxia is present at menstruation and drives endometrial repair post menses. However, detection of human endometrial hypoxia in vivo remains elusive. STUDY DESIGN, SIZE, DURATION: We performed a prospective case study of 16 women with normal menstrual bleeding. PARTICIPANTS/MATERIALS, SETTING, METHODS: Reproductively aged female participants with a regular menstrual cycle underwent objective measurement of their menstrual blood loss using the alkaline haematin method to confirm a loss of <80 ml per cycle. Exclusion criteria were exogenous hormone use, an intrauterine device, endometriosis or fibroids >3 cm. Participants attended for two MRI scans; during days 1-3 of menstruation and the early/mid-secretory phase of their cycle. The MRI protocol included dynamic contrast-enhanced MRI and T2* quantification. At each visit, an endometrial sample was also collected and hypoxia-regulated repair factor mRNA levels (ADM, VEGFA, CXCR4) were quantified by RT-qPCR. MAIN RESULTS AND THE ROLE OF CHANCE: Women had reduced T2* during menstrual scans versus non-menstrual scans (P = 0.005), consistent with menstrual hypoxia. Plasma flow (Fp) was increased at menstruation compared to the non-menstrual phase (P = 0.0005). Laboratory findings revealed increased ADM, VEGF-A and CXCR4 at menstruation on examination of paired endometrial biopsies from the menstrual and non-menstrual phase (P = 0.008; P = 0.03; P = 0.009). There was a significant correlation between T2* and these ex vivo hypoxic markers (P < 0.05). LIMITATIONS, REASONS FOR CAUTION: This study examined the in vivo detection of endometrial hypoxic markers at specific timepoints in the menstrual cycle in women with a menstrual blood loss <80 ml/cycle and without significant uterine structural abnormalities. Further research is required to determine the presence of endometrial hypoxia in those experiencing abnormal uterine bleeding with and without fibroids/adenomyosis. WIDER IMPLICATIONS OF THE FINDINGS: Heavy menstrual bleeding (HMB) is a common, debilitating condition. Understanding menstrual physiology may improve therapeutics. To our knowledge, this is the first in vivo data supporting the presence of menstrual hypoxia in the endometrium of women with normal menstrual bleeding. If aberrant in those with HMB, these non-invasive tests may aid diagnosis and facilitate personalized treatments for HMB. STUDY FUNDING/COMPETING INTEREST(S): This work was funded by Wellbeing of Women grant RG1820, Wellcome Trust Fellowship 209589/Z/17/Z and undertaken in the MRC Centre for Reproductive Health, funded by grants G1002033 and MR/N022556/1. H.O.D.C. has clinical research support for laboratory consumables and staff from Bayer AG and provides consultancy advice (but with no personal remuneration) for Bayer AG, PregLem SA, Gedeon Richter, Vifor Pharma UK Ltd, AbbVie Inc; Myovant Sciences GmbH. H.O.D.C. receives royalties from UpToDate for articles on abnormal uterine bleeding. TRIAL REGISTRATION NUMBER: N/A.
引用
- Reavey JJ, Walker C, Nicol M, et al. Markers of human endometrial hypoxia can be detected in vivo and ex vivo during physiological menstruation. Hum Reprod. 2021. PMID: 33496337. doi:10.1093/humrep/deaa379
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。